BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 17909068)

  • 1. SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis.
    Tsuchiya N; Ochiai M; Nakashima K; Ubagai T; Sugimura T; Nakagama H
    Cancer Res; 2007 Oct; 67(19):9568-76. PubMed ID: 17909068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA, SND1, and alterations in translational regulation in colon carcinogenesis.
    Tsuchiya N; Nakagama H
    Mutat Res; 2010 Nov; 693(1-2):94-100. PubMed ID: 20883704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent.
    Chen T; Turner J; McCarthy S; Scaltriti M; Bettuzzi S; Yeatman TJ
    Cancer Res; 2004 Oct; 64(20):7412-9. PubMed ID: 15492264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.
    Vécsey-Semjén B; Becker KF; Sinski A; Blennow E; Vietor I; Zatloukal K; Beug H; Wagner E; Huber LA
    Oncogene; 2002 Jul; 21(30):4646-62. PubMed ID: 12096341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein Kinase-zeta inhibits collagen I-dependent and anchorage-independent growth and enhances apoptosis of human Caco-2 cells.
    Mustafi R; Cerda S; Chumsangsri A; Fichera A; Bissonnette M
    Mol Cancer Res; 2006 Sep; 4(9):683-94. PubMed ID: 16940160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term administration of sulindac on APC mRNA and apoptosis in colons of rats treated with azoxymethane.
    Kishimoto Y; Yashima K; Morisawa T; Ohishi T; Marumoto A; Sano A; Idobe-Fujii Y; Miura N; Shiota G; Murawaki Y; Hasegawa J
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):589-95. PubMed ID: 12458338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients.
    Chen LC; Hao CY; Chiu YS; Wong P; Melnick JS; Brotman M; Moretto J; Mendes F; Smith AP; Bennington JL; Moore D; Lee NM
    Cancer Res; 2004 May; 64(10):3694-700. PubMed ID: 15150130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.
    Brunschwig EB; Wilson K; Mack D; Dawson D; Lawrence E; Willson JK; Lu S; Nosrati A; Rerko RM; Swinler S; Beard L; Lutterbaugh JD; Willis J; Platzer P; Markowitz S
    Cancer Res; 2003 Apr; 63(7):1568-75. PubMed ID: 12670906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of caveolin-1 in experimental colon adenocarcinomas and human colon cancer cell lines.
    Patlolla JM; Swamy MV; Raju J; Rao CV
    Oncol Rep; 2004 May; 11(5):957-63. PubMed ID: 15069532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-catenin regulates multiple steps of RNA metabolism as revealed by the RNA aptamer in colon cancer cells.
    Lee HK; Kwak HY; Hur J; Kim IA; Yang JS; Park MW; Yu J; Jeong S
    Cancer Res; 2007 Oct; 67(19):9315-21. PubMed ID: 17909039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Truncated APC regulates the transcriptional activity of beta-catenin in a cell cycle dependent manner.
    Schneikert J; Grohmann A; Behrens J
    Hum Mol Genet; 2007 Jan; 16(2):199-209. PubMed ID: 17189293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
    Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
    Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer.
    Luo L; Shen GQ; Stiffler KA; Wang QK; Pretlow TG; Pretlow TP
    Carcinogenesis; 2006 Jun; 27(6):1153-9. PubMed ID: 16474178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis.
    Gökmen-Polar Y; Murray NR; Velasco MA; Gatalica Z; Fields AP
    Cancer Res; 2001 Feb; 61(4):1375-81. PubMed ID: 11245437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer.
    Nambiar PR; Nakanishi M; Gupta R; Cheung E; Firouzi A; Ma XJ; Flynn C; Dong M; Guda K; Levine J; Raja R; Achenie L; Rosenberg DW
    Cancer Res; 2004 Sep; 64(18):6394-401. PubMed ID: 15374946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of colorectal cancers correlates with overexpression and loss of polarization of expression of the htid-1 tumor suppressor.
    Kurzik-Dumke U; Hörner M; Czaja J; Nicotra MR; Simiantonaki N; Koslowski M; Natali PG
    Int J Mol Med; 2008 Jan; 21(1):19-31. PubMed ID: 18097612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ApcMin/+ mouse model of colon cancer: gene expression profiling in tumors.
    Leclerc D; Deng L; Trasler J; Rozen R
    J Cell Biochem; 2004 Dec; 93(6):1242-54. PubMed ID: 15486983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of TOMM34, which shows elevated expression in the majority of human colon cancers, as a novel drug target.
    Shimokawa T; Matsushima S; Tsunoda T; Tahara H; Nakamura Y; Furukawa Y
    Int J Oncol; 2006 Aug; 29(2):381-6. PubMed ID: 16820880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
    Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
    Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells.
    Li Q; Wu M; Wang H; Xu G; Zhu T; Zhang Y; Liu P; Song A; Gang C; Han Z; Zhou J; Meng L; Lu Y; Wang S; Ma D
    Cancer Lett; 2008 Mar; 261(1):55-63. PubMed ID: 18155831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.